A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

NCT03570359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Interferon Beta-1A
OTHER: Placebo

Sponsor

Synairgen Research Ltd.